Related Experiment Video
Updated: May 21, 2026
05:30
Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
Published on: November 8, 2024
Second trimester anti-angiogenic proteins and preeclampsia
Catherine L Haggerty1, Michael E Seifert, Gong Tang
1Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
Pregnancy Hypertension
|June 20, 2012
Summary
High levels of soluble fms-like tyrosine kinase-1 (sFlt1) and soluble endoglin (sEng) in early pregnancy may increase the risk of developing preeclampsia. This finding aids in understanding preeclampsia development.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Biomarkers in Pregnancy
Background:
- Preeclampsia is a serious pregnancy complication.
- Identifying early risk factors for preeclampsia is crucial for timely intervention.
- Soluble fms-like tyrosine kinase-1 (sFlt1) and soluble endoglin (sEng) are implicated in placental dysfunction.
Purpose of the Study:
- To investigate the association between second-trimester levels of sFlt1 and sEng and the subsequent risk of preeclampsia.
- To quantify the risk associated with elevated levels of these biomarkers.
Main Methods:
- A nested case-control study within the Danish National Birth Cohort.
- Inclusion of 211 preeclamptic women and 213 normotensive controls.
- Measurement of sFlt1 and sEng levels in early pregnancy (13-27 weeks gestation).
- Statistical analysis using generalized linear models with smoothing splines, adjusting for covariates.
Main Results:
- Doubling of sFlt1 levels was associated with a 39% increased risk of preeclampsia.
- Doubling of sEng levels was associated with a 74% increased risk of preeclampsia.
- These associations remained significant after adjusting for maternal factors.
Conclusions:
- Elevated second-trimester levels of sFlt1 and sEng are possibly associated with an increased risk of preeclampsia.
- These biomarkers may serve as potential early predictors for preeclampsia development.
- Further research is warranted to confirm these findings and explore clinical applications.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...